What is LathMized™ NAD+ and how is it different?

LathMized™ NAD+ is Harmover's proprietary oral NAD+ supplement using liposomal-hybrid encapsulation technology. Unlike standard oral NAD+, NR or NMN supplements which have bioavailability under 2%, LathMized™ protects NAD+ through digestion and delivers it directly into cells. The RENEWAL-NAD+ double-blind RCT (NCT07336836) confirmed a 53% intracellular increase in 5 days. Blood plasma NAD+ was unchanged — confirming cellular, not circulatory delivery.

What is NAD+ and what does it do in the body?

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every living cell and essential for over 500 enzymatic reactions — including mitochondrial energy production, DNA repair, sirtuin longevity activation, and cellular stress response. After age 40, NAD+ levels fall by more than 50%.

Why haven't other NAD+ supplements worked for me?

Standard oral NAD+, NR and NMN supplements have bioavailability under 2% — most are destroyed in the gut before reaching a cell. LathMized™ NAD+ delivers NAD+ directly in its active form, protected through digestion via liposomal-hybrid encapsulation.

How long before I feel the results?

The clinical trial showed measurable intracellular change within 5 days. Most members notice shifts in energy and mental sharpness within the first two weeks. Physical recovery, sleep quality, and metabolic changes build over 60–90 days.

What is the difference between the four protocols?

All four protocols share the same LathMized™ NAD+ base. Longevity is for healthy adults pursuing proactive cellular health. Liver Support is for NAFLD/NASH. Post-Viral Recovery is for long COVID and post-viral fatigue. Hormonal addresses perimenopause, menopause and andropause. Your practitioner confirms the right protocol.

Is LathMized™ NAD+ safe? Are there side effects?

The RENEWAL-NAD+ trial reported zero serious adverse events across all 60 participants. One person experienced mild transient nausea (Grade 1), which resolved without intervention. Liver and kidney function remained normal throughout.

Tell me about the clinical trial — what exactly was tested?

The RENEWAL-NAD+ study (NCT07336836) was a randomised, double-blind, placebo-controlled trial conducted with the Institute of Systems Biology (Seattle) and approved by Western IRB. 60 adults aged 45–75. Primary endpoint: intracellular NAD+ in PBMCs — increased 53% in 5 days. SIRT1 increased 32%. 9 of 12 hallmarks of ageing positively impacted. Zero serious adverse events. Published bioRxiv 2026, DOI: 10.64898/2026.03.25.714130.

Where do you ship? Is this a prescription product?

Harmover ships to the United Kingdom, European Union, United States, and Canada. LathMized™ NAD+ is classified as a dietary supplement in all four markets, manufactured under cGMP standards in the USA. It is not a controlled substance or prescription-only product.

into main